Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
54.87
+0.29 (0.53%)
After Hours: 54.88 +0.01 (0.02%)
Feb 23, 5:16PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 54.57 - 55.00
52 week 53.36 - 66.80
Open 54.82
Vol / Avg. 9.06M/15.05M
Mkt cap 149.49B
P/E 29.13
Div/yield 0.48/3.50
EPS 1.88
Shares 2.72B
Beta 0.75
Inst. own 76%
May 22, 2018
Merck & Co Inc Annual Shareholders Meeting Add to calendar
May 1, 2018
Q1 2018 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
May 1, 2018
Q1 2018 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
Mar 13, 2018
Merck & Co Inc at Cowen Health care Conference - 11:20AM EDT - Add to calendar
Feb 27, 2018
Merck & Co Inc at Credit Suisse Global Healthcare Conference Add to calendar
Feb 26, 2018
Merck & Co Inc at CECP CEO Investor Forum - 3:00PM EST - Add to calendar
Feb 2, 2018
Q4 2017 Merck & Co Inc Earnings Release
Feb 2, 2018
Q4 2017 Merck & Co Inc Earnings Call - Webcast
Jan 8, 2018
Merck & Co Inc at JPMorgan Healthcare Conference - Webcast
Dec 7, 2017
Merck & Co Inc at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 16.64% 12.94%
Operating margin 19.99% 16.85%
EBITD margin - 18.78%
Return on average assets - -
Return on average equity - -
Employees 68,000 -
CDP Score - B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 62
Bio & Compensation  - Reuters
Sanat Chattopadhyay Executive Vice President and President - Merck Manufacturing Division
Age: 57
Bio & Compensation  - Reuters
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 54
Bio & Compensation  - Reuters
Julie Louise Gerberding M.D. Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health
Age: 61
Bio & Compensation  - Reuters
Roger M. Perlmutter M.D. Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 65
Bio & Compensation  - Reuters
Adam H. Schechter Executive Vice President, President - Global Human Health
Age: 52
Bio & Compensation  - Reuters
Rita A. Karachun Senior Vice President Finance - Global Controller
Age: 53
Bio & Compensation  - Reuters